Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
-Medical News
 Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory

 

 

 
Armenian Government and Hemophilia Organization Confront Treatment Access
 

In an effort to address the treatment needs of its hemophilia population, the Armenian government will purchase approximately $60,000 worth of factor VIII (FVIII) product. The Armenian Health Care Ministry will attempt to build on this purchase by including a permanent FVIII allocation in future budgets to provide treatment for the approximately 260 Armenians with hemophilia. The World Federation of Hemophilia has been working with Armenia and other governments worldwide to help augment hemophilia treatment resources.

 

In addition, David Khanzratyan, vice president of the Armenian Association of Hemophilia Patients, has stated that a hemophilia treatment center and laboratory will open at the Blood Transfusion Institute in the capital city of Yerevan. It is estimated that approximately 75% of the world hemophilia population goes without adequate treatment.

 

Source: ARMINFO News Agency (Armenia), November 16, 2005

 

This section of our Web site is sponsored by: